1. Home
  2. VBF vs PROF Comparison

VBF vs PROF Comparison

Compare VBF & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VBF
  • PROF
  • Stock Information
  • Founded
  • VBF 1970
  • PROF N/A
  • Country
  • VBF United States
  • PROF Canada
  • Employees
  • VBF N/A
  • PROF N/A
  • Industry
  • VBF Trusts Except Educational Religious and Charitable
  • PROF Medical/Dental Instruments
  • Sector
  • VBF Finance
  • PROF Health Care
  • Exchange
  • VBF Nasdaq
  • PROF Nasdaq
  • Market Cap
  • VBF 172.3M
  • PROF 140.9M
  • IPO Year
  • VBF N/A
  • PROF N/A
  • Fundamental
  • Price
  • VBF $15.47
  • PROF $4.63
  • Analyst Decision
  • VBF
  • PROF Strong Buy
  • Analyst Count
  • VBF 0
  • PROF 2
  • Target Price
  • VBF N/A
  • PROF $11.50
  • AVG Volume (30 Days)
  • VBF 45.5K
  • PROF 76.3K
  • Earning Date
  • VBF 01-01-0001
  • PROF 05-08-2025
  • Dividend Yield
  • VBF 5.18%
  • PROF N/A
  • EPS Growth
  • VBF N/A
  • PROF N/A
  • EPS
  • VBF N/A
  • PROF N/A
  • Revenue
  • VBF N/A
  • PROF $11,862,000.00
  • Revenue This Year
  • VBF N/A
  • PROF $71.17
  • Revenue Next Year
  • VBF N/A
  • PROF $134.25
  • P/E Ratio
  • VBF N/A
  • PROF N/A
  • Revenue Growth
  • VBF N/A
  • PROF 75.01
  • 52 Week Low
  • VBF $13.68
  • PROF $3.90
  • 52 Week High
  • VBF $16.27
  • PROF $11.42
  • Technical
  • Relative Strength Index (RSI)
  • VBF 57.16
  • PROF 39.95
  • Support Level
  • VBF $15.26
  • PROF $4.62
  • Resistance Level
  • VBF $15.55
  • PROF $5.62
  • Average True Range (ATR)
  • VBF 0.16
  • PROF 0.40
  • MACD
  • VBF 0.03
  • PROF 0.06
  • Stochastic Oscillator
  • VBF 88.24
  • PROF 18.79

About VBF Invesco Bond Fund

Invesco Bond Fund is an independent investment management firm. Its investment objective is to seek interest income while conserving capital.

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

Share on Social Networks: